Focusing Management Resources on Healthcare Information Services and Medium-Term Growth
First written in FY2016. 23 of 39 entries say "Restated". Latest entry: 2026-08-05.
No other company in this theme has enough history to compare yet.
- 2026-08-05AdvancedEarnings presentation
「Net sales: targeting ¥6 billion through growth in both data health and data utilization services Operating income: targeting ¥400 million through net sales growth and improved productivity」
For the fiscal year ending March 2027, the Company set specific annual targets of ¥6 billion in net sales and ¥400 million in operating income, based on growth in its 2 existing businesses and higher productivity. - FY2026AchievedAnnual report
「To achieve this, in the fiscal year ending March 2026, we achieved substantial year-on-year net sales growth and monetization through investments and structural reforms made through the previous fiscal year, and achieved profitability.」
Regarding its monetization and growth plan for the next 3 years, the company states that it achieved profitability in the fiscal year ending March 2026 through investment and structural reforms. - FY2026-H1AdvancedAnnual report
「Orders for fiscal 2025 projects for municipal National Health Insurance, which form the basis for full-year net sales in the fiscal year ending March 2026, have already exceeded the full-year order results for fiscal 2024, and the number of orders is growing steadily.」
The company states that orders for fiscal 2025 municipal National Health Insurance projects exceeded the full-year results for fiscal 2024, indicating progress in orders for data health-related services. - FY2025RaisedAnnual report
「Over the next 3 years, we aim to monetize the business by revitalizing and improving the efficiency of data health-related services and achieving strong growth in data utilization services, placing these existing businesses on a stable growth trajectory while making disciplined investments in new businesses and other areas to achieve sustainable growth.」
The company has translated its previous growth policy into a plan for the next 3 years to achieve renewed growth and greater efficiency in data health, growth and monetization in data utilization, and disciplined investment in new businesses. - FY2025-H1Progress in medium-term comparisonAnnual report
「Under these circumstances, although net sales from data health-related services during the current interim consolidated accounting period declined year on year due to a reactionary decline in orders related to the third Data Health Plan, they were 21% higher than two fiscal years earlier. To expand transactions over the medium term, we are actively pursuing sales activities by leveraging the record-high number of customers achieved last fiscal year.」
Although net sales declined year on year due to a reactionary decline in orders for the third Data Health Plan, they were 21% higher than two fiscal years earlier, and the company is pursuing sales activities by leveraging its record-high number of customers. - FY2024RaisedAnnual report
「For our Group's core data health-related services, we aim for 500 municipalities to adopt the services in a single fiscal year and a 30% market share by expanding regional market share and sales regions, commercializing preventive care services, expanding health improvement services for prefectures through stronger analytical capabilities, and expanding adoption of services such as kencom.」
In addition to its previous policy of expanding net sales and orders, the company has set specific targets of 500 municipalities adopting its services in a single fiscal year and a 30% market share. - FY2024-Q3AdvancedAnnual report
「Under these circumstances, our Group's net sales for the first nine months of the current fiscal year increased by ¥752 million from the same period of the previous year to ¥4,003 million, up 23.2% year on year. The smooth receipt and delivery of orders for support services for preparing the third Data Health Plan for municipal National Health Insurance, together with a record-high number of contracted insurers, led to a ¥638 million increase in net sales from the legacy Group, on the same basis of composition as in the same period of the previous year, while the consolidation of DeSC as a subsidiary contributed ¥114 million.」
Orders and delivery of support services for preparing the third Data Health Plan, together with a record-high number of contracted insurers, resulted in a 23.2% year-on-year increase in net sales. The company separately discloses the contributions from the legacy Group and the consolidation of DeSC as a subsidiary. - FY2024-Q2AdvancedAnnual report
「Under these circumstances, our Group's net sales for the first six months of the current fiscal year increased by ¥662 million from the same period of the previous year to ¥2,372 million, up 38.7% year on year. The smooth receipt and delivery of orders for support services for preparing the third Data Health Plan for municipal National Health Insurance, together with the expected record-high number of contracted insurers, led to a ¥374 million increase in net sales from the legacy Group, on the same basis of composition as in the same period of the previous year, while the consolidation of DeSC as a subsidiary contributed ¥288 million.」
Orders and delivery of support services for preparing the third Data Health Plan progressed smoothly, resulting in a 38.7% year-on-year increase in net sales. The company separately discloses the increases attributable to higher net sales from the legacy Group and the consolidation of DeSC as a subsidiary. - FY2024-Q1AdvancedAnnual report
「Under these circumstances, our Group's net sales for the first quarter of the current fiscal year increased by ¥456 million from the same period of the previous year to ¥1,177 million, up 63.3% year on year. The smooth receipt and delivery of orders for support services for preparing the third Data Health Plan for municipal National Health Insurance led to a ¥246 million increase in net sales from the legacy Group, on the same basis of composition as in the same period of the previous year, while the consolidation of DeSC as a subsidiary contributed ¥209 million.」
The company states that the smooth receipt and delivery of orders for support services for preparing the third Data Health Plan for municipal National Health Insurance increased net sales from the legacy Group by ¥246 million. - FY2023-Q3RaisedAnnual report
「Going forward, we aim to achieve stable growth in our data health-related business and launch our data utilization business with strong momentum. Net sales from the data utilization business, which we launched in cooperation with DeSC from the previous fiscal year, amounted to ¥692 million and are growing steadily.」
In addition to growth in the existing data health-related business, the company has launched the data utilization business as a new growth area and disclosed net sales of ¥692 million for the first nine months of the current fiscal year. - FY2023-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2022RestatedAnnual report
「For our Group's core data health-related services, we aim to maintain year-on-year net sales growth of 20% by expanding regional market share and sales regions, commercializing preventive care services, expanding health improvement services for prefectures through stronger analytical capabilities, and expanding through stronger guidance systems for preventing the progression of severe illness.」
For data health-related services, the company continues to target 20% year-on-year net sales growth through expanded sales regions and regional market share, commercialization of preventive care services, businesses for prefectures and prevention of the progression of severe illness. - FY2022-Q3RaisedAnnual report
「In terms of costs, we strengthened our service delivery structure with the aim of increasing net sales by 20%. We also invested in research and development for strengthening our sales and service delivery structures and for new businesses, including systems and data utilization businesses addressing the digital transformation of local governments, in preparation for expanding remote guidance to prevent the progression of severe illness in the fiscal year ending June 2023 and for the expected substantial increase in demand, centered on preparing the third Data Health Plan in the fiscal year ending June 2024.」
Compared with the previous policy of expanding net sales and ordinary profit, the company specifies a target of 20% net sales growth, a concrete timeline covering the fiscal years ending June 2023 and June 2024, and strengthened sales and service delivery structures and research and development investment in new businesses. - FY2022-Q2RestatedAnnual report
「During the first six months of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2021RestatedAnnual report
「Against this operating backdrop, our Group aims to convert this demand into orders through proactive sales activities and expand its market share and net sales. We will also invest in research and development for the future, aimed at developing new services and enhancing the functions of existing services, at a level exceeding 5% of net sales, and will target an increase in ordinary profit.」
The company continues to pursue the targets of converting demand into orders, expanding market share and net sales, investing at a level exceeding 5% of net sales in research and development, and increasing ordinary profit. - FY2021-Q3RestatedAnnual report
「During the first nine months of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2021-Q2RestatedAnnual report
「During the first six months of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2021-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2020Specifying targetsAnnual report
「Against this operating backdrop, our Group aims to convert this demand into orders through proactive sales activities and expand its market share and net sales. We will also invest in research and development for the future, aimed at developing new services and enhancing the functions of existing services, at a level exceeding 5% of net sales, and will target an increase in ordinary profit.」
In addition to its targets for expanding market share and net sales, the company specifies that it will invest in research and development at a level exceeding 5% of net sales and target an increase in ordinary profit. - FY2020-Q3RestatedAnnual report
「During the first nine months of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2020-Q2RestatedAnnual report
「During the first six months of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2019RestatedAnnual report
「We aim to convert this demand into orders and expand our market share and net sales. We will also advance sales activities and system development to expand our notification business for multi-medication information, which addresses polypharmacy.」
The company reaffirms its policy of converting data health demand into increased orders, market share and net sales, as well as its sales activities and system development related to polypharmacy. - FY2019-Q3RestatedAnnual report
「During the first nine months of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2019-Q2RestatedAnnual report
「During the first six months of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2019-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2018RestatedAnnual report
「Our Group will concentrate its management resources on the healthcare information services business and pursue medium-term growth by enhancing data health-related services, whose promotion as a national policy began in the fiscal year ended March 2015, and expanding the regions in which they are sold.」
The company reaffirms its policy of pursuing medium-term growth by concentrating management resources on healthcare information services, enhancing services and expanding sales regions. - FY2018-Q3RestatedAnnual report
「During the first nine months of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2018-Q2RestatedAnnual report
「During the first six months of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company reaffirms that there are no material changes in the current status and outlook of its management strategy. - FY2018-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, there were no material changes in the factors having a significant impact on our Group's business performance or in the current status and outlook of our management strategy.」
The company explicitly states that there are no material changes in the current status and outlook of its management strategy. - FY2017RestatedAnnual report
「Our Group will concentrate its management resources on the healthcare information services business and pursue medium-term growth by enhancing data health-related services, whose promotion as a national policy began in the fiscal year ended March 2015, and expanding the regions in which they are sold.」
The company continues its policy of pursuing medium-term growth by concentrating management resources on healthcare information services, enhancing services and expanding sales regions. - FY2017-Q3RestatedAnnual report
「During the first nine months of the current fiscal year, there were no material changes in the factors having a significant impact on our business performance or in the current status and outlook of our management strategy.」
The company explicitly states that there are no material changes in the current status and outlook of its management strategy. - FY2017-Q2RestatedAnnual report
「Under these circumstances, during the first six months of the current fiscal year, we actively promoted sales of data health-related services through our information services for insurers.」
The company has continued promoting sales of data health-related services through its information services for insurers. - FY2017-Q1RestatedAnnual report
「Under these circumstances, during the first quarter of the current fiscal year, we actively promoted sales of data health-related services through our information services for insurers.」
The company has continued promoting sales of data health-related services through its information services for insurers. - FY2016RestatedAnnual report
「We will concentrate our management resources on the healthcare information services business and pursue medium-term growth by enhancing data health-related services, whose promotion as a national policy began in the fiscal year ended March 2015, and expanding the regions in which they are sold.」
The company reiterates its policy of pursuing medium-term growth by concentrating management resources on healthcare information services, enhancing services and expanding sales regions. - FY2016First statedAnnual report
「We will concentrate our management resources on the healthcare information services business and pursue medium-term growth by enhancing data health-related services, whose promotion as a national policy began in the fiscal year ended March 2015, and expanding the regions in which they are sold.」
The company identifies business focus, enhanced services and expanded sales regions as means of achieving growth.